Agilon Health Inc. (NYSE: AGL) reported Q3 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $459 million versus the consensus estimate of $448.81 million.

GUIDANCE:

Agilon Health Inc. sees Q4 2021 revenue of $1.82-1.825 billion, versus the consensus of $1.81 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.